Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Clinical trial NCT06010862 · RECRUITING

Trial details

NCT number: NCT06010862
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Colon Cancer Pancreas Cancer Esophagus Cancer Cholangiocarcinoma Lung Cancer Breast Cancer

Start date: 2023-09-30
Primary completion: 2025-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.